Filing Details
- Accession Number:
- 0001104659-23-000023
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-03 06:04:27
- Reporting Period:
- 2022-12-29
- Accepted Time:
- 2023-01-03 06:04:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 894158 | Theriva Biologics Inc. | TOVX | Pharmaceutical Preparations (2834) | 133808303 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1263501 | A Steven Shallcross | C/O Theriva Biologics, Inc., 9605 Medical Center Drive, Suite 270 Rockville MD 20850 | Ceo And Cfo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-29 | 100,000 | $0.44 | 110,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
